Articles by tag: Antiviral
Latest
Ericsson and the Convergence of 5G and Automation in Manufacturing
The Convergence of 5G and Automation in Manufacturing: A New Industrial Revolution The manufacturing industry stands at an inflection point. Advances in 5G technology and automation are coming together to transform the way products are made, and the role that humans and machines play in this process. Per Treven, Director of Business Development at Ericsson, […]
Drone Delivery Faces Cybersecurity Threats, But Advanced IoT Can Be its Resolution
Cybersecurity in beyond visual line-of-sight drone delivery is critical and this makes for a pressing need to shield Internet of Things (IoT) systems, particular advanced IoT. With the FAA granting UPS the green light to perform drone deliveries, there are some concerns. Some experts emphasize the importance of leveraging cybersecurity measures to protect […]
Personalizing the Dining Experience Through Music
When people go to a restaurant, personalizing the dining experience is a critical factor in making an impact that keeps customers returning. What better way to capitalize on that experience than through music? In recent years, the restaurant industry has seen a significant shift towards personalizing the dining experience for guests. As the industry […]
What Can the Pharma Industry Learn from Merck’s New Antiviral?
Merck is one of the first pharmaceutical companies to submit an antiviral candidate to the FDA for approval, signaling the beginning of a new phase of mass production of COVID treatment drugs. For Merck’s oral antiviral, molnupiravir, its optimistic success can be largely credited to its federal funding. Work on the related compound was […]
How Does the COVID-19 Antiviral Medications Workflow Compare to the Traditional Antiviral Production Pipeline
As the COVID-19 pandemic continues to progress researchers and scientists are starting to learn more about the virus in order to effectively combat it. One of those lessons is how the COVID-19 virus compares to other viruses when it comes to developing treatments. Justin Honore talked to Dr. Kishor Wasan, PH.D.,FAAPS, FCAHS, FCSPS, Chief […]
With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?
At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% […]